According to a recent literature review, general HRQoL instruments were not used in any of the clinical trials included. Two observational studies reported the SF-12, SF-36, and EQ-5D-5L. The study found that, of the 18 measures identified, most studies (> 50%) included the Female Sexual Distress Scale-Revised (FSDS-R) and the Female Sexual Function Index (FSFI).
No instruments achieved positive quality ratings across all psychometric criteria. The only measures to receive a positive rating for content validity were the FSDS-R, FSFI, the Sexual Desire Relationship Distress Scale, and the Sexual Event Diary. Researchers concluded that, in order to provide a more systematic and comprehensive assessment of HRQoL and treatment benefits in women with HSDD/FSIAD, reliable and valid HRQoL measures that include sexual desire and distress are needed.
Learn more about female sexual dysfunction.
This Rapid Review Quiz was excerpted and adapted from the Medscape articles: Bremelanotide, Phosphodiesterase-5 Enzyme Inhibitors, Flibanserin, Sildenafil, and Female Sexual Dysfunction.
Credits:
Lead image: Prostockstudio/Dreamstime
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. Rapid Rx Quiz: Sexual Desire and Performance Medications - Medscape - Apr 11, 2022.
